Publications by authors named "Mahsa S Talbott"

Claim this Profile
D
Durable responses in refractory autoimmune hemolytic anemia with alemtuzumab.
Renee K McAlister, Mahsa S Talbott, Nishitha M Reddy

J Oncol Pharm Pract· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased serum tumor necrosis factor α levels in patients with lenalidomide-induced hypothyroidism.
Wade T Iams, Megan L Hames, Judy P Tsai, Kimberly B Dahlman, Mahsa S Talbott

Exp Hematol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profile of belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma.
Andrew Bodiford, Megan Bodge, Mahsa S Talbott, Nishitha M Reddy

Onco Targets Ther· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of the microculture-kinetic drug-induced apoptosis assay with patient outcomes in initial treatment of adult acute myelocytic leukemia.
Stephen A Strickland, Anastasios Raptis, Allan Hallquist, James Rutledge, Michael Chernick, Mahsa S Talbott

Leuk Lymphoma· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicities and outcomes among septuagenarians and octogenarians with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapy.
Scott F Huntington, Mahsa S Talbott, John P Greer, David S Morgan, Nishitha Reddy

Leuk Lymphoma· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis